Auer S, Schicht M, Hoffmann L, Budday S, Frischknecht R, Blumcke I
Cells. 2025; 14(5).
PMID: 40072050
PMC: 11898492.
DOI: 10.3390/cells14050321.
Mangiardi M, Pezzella F, Cruciani A, Alessiani M, Anticoli S
J Pers Med. 2024; 14(12).
PMID: 39728038
PMC: 11679913.
DOI: 10.3390/jpm14121125.
Ishii T, Kaya M, Muroi Y
Int J Mol Sci. 2024; 25(17).
PMID: 39273208
PMC: 11395544.
DOI: 10.3390/ijms25179259.
Mirzababaei M, Babaei F, Ghafghazi S, Rahimi Z, Asadi S, Dargahi L
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1625-1635.
PMID: 39141021
DOI: 10.1007/s00210-024-03361-8.
Woo A, Sontheimer H
Front Mol Med. 2024; 3:1198021.
PMID: 39086689
PMC: 11285605.
DOI: 10.3389/fmmed.2023.1198021.
Blood-brain barrier dysfunction and decreased transcription of tight junction proteins in epileptic dogs.
Hanael E, Baruch S, Altman R, Chai O, Rapoport K, Peery D
J Vet Intern Med. 2024; 38(4):2237-2248.
PMID: 38842297
PMC: 11256172.
DOI: 10.1111/jvim.17099.
Structural and functional reorganization of inhibitory synapses by activity-dependent cleavage of neuroligin-2.
Xu N, Cao R, Chen S, Gou X, Wang B, Luo H
Proc Natl Acad Sci U S A. 2024; 121(18):e2314541121.
PMID: 38657049
PMC: 11067042.
DOI: 10.1073/pnas.2314541121.
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment.
Ravizza T, Scheper M, Di Sapia R, Gorter J, Aronica E, Vezzani A
Nat Rev Neurosci. 2024; 25(5):334-350.
PMID: 38531962
DOI: 10.1038/s41583-024-00805-1.
AQP4 Endocytosis-Lysosome Degradation Mediated by MMP-9/β-DG Involved in Diabetes Cognitive Impairment.
Yuan Y, Peng W, Lei J, Zhao Y, Zhao B, Li Y
Mol Neurobiol. 2024; 61(10):8438-8453.
PMID: 38512439
DOI: 10.1007/s12035-024-04085-9.
Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
Feng H, Clatot J, Kaneko K, Flores-Mendez M, Wengert E, Koutcher C
Cell Rep Med. 2024; 5(2):101389.
PMID: 38266642
PMC: 10897515.
DOI: 10.1016/j.xcrm.2023.101389.
Matrix Metalloproteinase-9 Contributes to Epilepsy Development after Ischemic Stroke in Mice.
Pijet B, Kostrzewska-Ksiezyk A, Pijet-Kucicka M, Kaczmarek L
Int J Mol Sci. 2024; 25(2).
PMID: 38255970
PMC: 10815104.
DOI: 10.3390/ijms25020896.
Developmental Regulation of Matrix Metalloproteinases in Response to Multifactorial, Severe Traumatic Brain Injuries during Immaturity.
Hochstetler A, Price G, Baohan A, Li M, Rodriguez Lara F, Lok J
Dev Neurosci. 2024; 46(5):319-332.
PMID: 38190820
PMC: 11228128.
DOI: 10.1159/000536054.
Increased expression of chondroitin sulfate proteoglycans in dentate gyrus and amygdala causes postinfectious seizures.
Patel D, Swift N, Tewari B, Browning J, Prim C, Chaunsali L
Brain. 2023; 147(5):1856-1870.
PMID: 38146224
PMC: 11068111.
DOI: 10.1093/brain/awad430.
BDNF signaling requires Matrix Metalloproteinase-9 during structural synaptic plasticity.
Legutko D, Kuzniewska B, Kalita K, Yasuda R, Kaczmarek L, Michaluk P
bioRxiv. 2023; .
PMID: 38106209
PMC: 10723398.
DOI: 10.1101/2023.12.08.569797.
Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome.
Aishworiya R, Chi M, Zafarullah M, Mendoza G, Ponzini M, Kim K
Cells. 2023; 12(14).
PMID: 37508583
PMC: 10377864.
DOI: 10.3390/cells12141920.
Infection-induced epilepsy is caused by increased expression of chondroitin sulfate proteoglycans in hippocampus and amygdala.
Patel D, Swift N, Tewari B, Browning J, Prim C, Chaunsali L
bioRxiv. 2023; .
PMID: 37292901
PMC: 10245664.
DOI: 10.1101/2023.05.16.541066.
Does the functional polymorphism-1562C/T of MMP-9 gene influence brain disorders?.
Pabian-Jewula S, Rylski M
Front Cell Neurosci. 2023; 17:1110967.
PMID: 37206663
PMC: 10188926.
DOI: 10.3389/fncel.2023.1110967.
Extracellular Matrix Regulation in Physiology and in Brain Disease.
Soles A, Selimovic A, Sbrocco K, Ghannoum F, Hamel K, Moncada E
Int J Mol Sci. 2023; 24(8.
PMID: 37108212
PMC: 10138624.
DOI: 10.3390/ijms24087049.
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI).
Cirillo G, Pepe R, Siciliano M, Ippolito D, Ricciardi D, de Stefano M
Int J Mol Sci. 2023; 24(4).
PMID: 36834642
PMC: 9961904.
DOI: 10.3390/ijms24043231.
Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs.
Lukasiuk K, Lason W
Int J Mol Sci. 2023; 24(3).
PMID: 36769250
PMC: 9917847.
DOI: 10.3390/ijms24032928.